Inflammatory bowel diseases may be detectable at birth
Across the Western world, the prevalence of these chronic and serious conditions, which have no cure, is rising. In Denmark alone, 50,000 people suffer from either Crohn’s disease or ulcerative…
Moderately to everely active Ulcerative Colitis, European Commission approves Pfizer’s etrasimod (Velsipity®)
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for VELSIPITY® (etrasimod) in the European Union to treat patients 16 years of age and…